share_log

Anhui Conch Cement (OTCMKTS:AHCHY) Stock Price Passes Below 50 Day Moving Average of $20.45

Defense World ·  Sep 7, 2022 03:41

Anhui Conch Cement Company Limited (OTCMKTS:AHCHY – Get Rating) crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $20.45 and traded as low as $18.61. Anhui Conch Cement shares last traded at $18.70, with a volume of 31,403 shares trading hands.

Analyst Ratings Changes

Separately, The Goldman Sachs Group cut shares of Anhui Conch Cement from a "neutral" rating to a "sell" rating in a research note on Sunday, August 28th.

Get Anhui Conch Cement alerts:

Anhui Conch Cement Stock Performance

The firm's 50 day moving average is $20.45 and its 200-day moving average is $23.58.

About Anhui Conch Cement

(Get Rating)

Anhui Conch Cement Company Limited, together with its subsidiaries, manufactures, sells, and trades in clinker and cement products. The company conducts its operations through five segments, which include Eastern China, Central China, Southern China, Western China, and Overseas. It provides construction and installation services for industrial purposes; logistic services; and mining and related services.

See Also

  • Get a free copy of the StockNews.com research report on Anhui Conch Cement (AHCHY)
  • 3 Low Beta Defensive Stocks for a Tough Market
  • It Could Be a September to Remember for These 3 Stocks
  • Peak Inflation Sets the Bottom for Brinker International Stock
  • Can Roblox Reverse its Falling Bookings Amid Rising Engagements
  • Broadcom Bounces From Institutional Bottom

Receive News & Ratings for Anhui Conch Cement Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anhui Conch Cement and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment